Hem › Graft-versus-host-sjukdom › Kalifornien
Kliniska studier för Graft-versus-host-sjukdom i Kalifornien
9 studier för Graft-versus-host-sjukdom söker deltagare vid platser i Kalifornien.
Städer i Kalifornien
Officiell studietext (engelska)
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- UCLA Department of Medicine, Los Angeles
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 7 juli 2026 · NCT07216443Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
- City of Hope Medical Center, Duarte
RekryterarFas 1
Ålder 18 till 75 · Alla kön · Uppdaterad 1 juli 2026 · NCT06996119Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
- City of Hope Medical Center, Duarte
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 29 juni 2026 · NCT06815003A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- University of Southern California Norris Comprehensive Cancer Center, Los Angeles
RekryterarFas 2
Ålder 2 och äldre · Alla kön · Uppdaterad 16 juni 2026 · NCT04710576A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Stanford Cancer Center, Palo Alto
- University of California San Francisco, San Francisco
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 20 maj 2026 · NCT06615050A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
- University of California, San Francisco, San Francisco
Rekryterar
Upp till ålder 30 · Alla kön · Uppdaterad 13 apr. 2026 · NCT04337515A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- City of Hope National Medical Center, Duarte
- Ronald Regan UCLA Medical Center, Los Angeles
- University of California Irvine Health, Orange
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 15 dec. 2025 · NCT06619561Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
- Stanford Hospital, Stanford
RekryterarObservationsstudie
36 Months · Alla kön · Uppdaterad 20 okt. 2025 · NCT05866302Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- City of Hope, Duarte
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 15 apr. 2025 · NCT06462365Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.